Patricio Múrias dos Santos

Patricio Múrias dos Santos is a seasoned biotechnology and pharmaceutical executive with over 18 years of experience in global commercial strategy and product launches. Currently serving as the Executive Director of Global Marketing at PTC Therapeutics, Patricio leads the preparation for the anticipated launch of a potential new treatment for phenylketonuria (PKU). Until recently, he drove the global strategy for the company’s pioneering gene therapy for Aromatic l-amino acid decarboxylase deficiency (AADCd). With expertise in rare diseases, gene therapy, and orphan drug commercialization, Patricio has a proven track record of leading cross-functional teams to bring innovative therapies to patients worldwide. Fluent in five languages, his international experience spans strategic marketing, commercial operations, and health policy. Patricio holds advanced degrees in Chemistry and Pharma Business, combining scientific insight with business acumen to expand global market reach and improve patient outcomes.